Study Details
A study to assess safety and efficacy of ASP1941 in combination with Nateglinide in type 2 diabetic patients
Clinicaltrials.gov ID
Astellas Study ID
1941-CL-0111
EudraCT ID
N/A
Condition
Adult Onset Diabetes
Phase
Phase 3
Age
20 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Jan 2011 - Oct 2012
Masking
None (Open Label)
Enrollment number
122
Phase III Study of ASP1941 - Open-label, Non-comparative Study to Assess the Long-term Safety, Tolerability and Efficacy of ASP1941 in Combination with Nateglinide in Japanese Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Nateglinide Alone
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to assess safety and efficacy of ASP1941 in combination with Nateglinide in type 2 diabetic patients? Contact us by filling our your information to the right and we’ll respond to you.